• Differentiating between complete and incomplete crush
• The importance of sequential crush and bigger balloons, adequately sized according to proximal vessel diameter

Commented by Goran Stankovic and William Wijns

Part 2 of a 3-part series:  
Previous episode: DK Crush like you’ve never seen it before
Coming up next: Main vessel stenting in DK-Crush, lessons...

• Optimisation of side branch stenting
• How to optimally deploy the second stent

Commented by Goran Stankovic and William Wijns

Part 3 of a 3-part series. Previous episode: How to correct incomplete crush and how to prevent lack of carina coverage

A 48‑year‑old man with hypertension and diabetes mellitus presented with a recent history of thrombolysed anterior acute MI and preserved left ventricular function. Coronary angiography revealed a severely calcified ostial LAD and ostial ramus lesion, along with diffuse disease of the RCA.

The ramus was treated with...

This session presents the future of TAVI valve design, emphasizing supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches tailored for long-term patient management.

This expert-led session offers an in-depth review of evolving clinical practices in aortic valve disease treatment, emphasizing the potential of the transcarotid approach as a primary alternative access route. It compares current strategies including TAVI, surgical aortic valve replacement (SAV), TAV-in-SAV, and TAVI explantation, while addressing...

This session offers an in-depth exploration of lifetime management strategies for patients undergoing Evolut first redo TAVI procedures, including TAV-in-TAV and explant techniques. It provides a comprehensive understanding of clinical decision-making algorithms, technical challenges, and key considerations for successful procedural planning and execution, supported by real-world...

This session develops a nuanced understanding of the complexity inherent in DMR cases, informed by the latest registry data. It highlights the capabilities of the PASCAL device in managing challenging anatomies and achieving predictable clinical results, alongside contemporary strategies for device selection and optimal placement to...

This session focuses on the evolving landscape of TAVI, emphasising lifetime management strategies with a focus on the first valve implanted. It provides a comprehensive discussion on representative patient profiles, current guidelines from various countries, and future outlooks, alongside recent long-term clinical results for the balloon-expandable...

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

This EIJ image highlights a new device designed to enhance the safety and efficiency of ViV TAVI procedures, particularly TAV-in-TAV, by reducing attempts to cross the valve and preventing guidewire misnavigation, thereby minimizing complications and procedure time.

An 85-year-old man presented in cardiogenic shock with torrential aortic regurgitation after prior surgical and TAVI valve-in-valve procedures. With high coronary obstruction risk, urgent CT assessment and in-silico simulations guided a rapid redo TAVI-in-TAVI-in-valve implantation, demonstrating that CT-assisted emergency redo-TAVI is feasible and lifesaving in high-risk...

Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.